MedPath

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
Device: Perimetry
Device: Confocal Scanning Laser Tomography
Device: Optical Coherence Tomography (OCT)
Registration Number
NCT00902109
Lead Sponsor
University Hospital Tuebingen
Brief Summary

The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • primary open angle glaucoma (POAG)
  • spherical ametropia max. ± 8 dpt
  • cylindrical ametropia max. ± 3 dpt
  • distant visual acuity > 10/20
  • pupil diameter > 3 mm
Exclusion Criteria
  • diabetic retinopathy
  • asthma
  • history of epilepsy or significant psychiatric disease
  • medications known to effect visual field sensitivity
  • infections (e.g., keratitis, conjunctivitis, uveitis)
  • severe dry eyes
  • miotic drug
  • squint
  • nystagmus
  • albinism
  • any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields
  • keratoconus
  • intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening
  • history or signs of any visual pathway affection other than glaucoma
  • history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
perimetry, HRT, OCTPerimetryperimetry, HRT, OCT
perimetry, HRT, OCTConfocal Scanning Laser Tomographyperimetry, HRT, OCT
perimetry, HRT, OCTOptical Coherence Tomography (OCT)perimetry, HRT, OCT
Primary Outcome Measures
NameTimeMethod
Comparison of rate of progression36 month

Perimetric measures every 3 month over 3 years

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute for Ophthalmic Research

🇩🇪

Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath